Abstract
A bacterium originally described as Hafnia alvei induces diarrhea in rabbits and causes epithelial damage similar to the attachment and effacement associated with enteropathogenic Escherichia coli. Subsequent studies identified similar H. alvei-like strains that are positive for an intimin gene (eae) probe and, based on DNA relatedness, are classified as a distinct Escherichia species, Escherichia albertii. We determined sequences for multiple housekeeping genes in five E. albertii strains and compared these sequences to those of strains representing the major groups of pathogenic E. coli and Shigella. A comparison of 2,484 codon positions in 14 genes revealed that E. albertii strains differ, on average, at ∼7.4% of the nucleotide sites from pathogenic E. coli strains and at 15.7% from Salmonella enterica serotype Typhimurium. Interestingly, E. albertii strains were found to be closely related to strains of Shigella boydii serotype 13 (Shigella B13), a distant relative of E. coli representing a divergent lineage in the genus Escherichia. Analysis of homologues of intimin (eae) revealed that the central conserved domains are similar in E. albertii and Shigella B13 and distinct from those of eae variants found in pathogenic E. coli. Sequence analysis of the cytolethal distending toxin gene cluster (cdt) also disclosed three allelic groups corresponding to E. albertii, Shigella B13, and a nontypeable isolate serologically related to S. boydii serotype 7. Based on the synonymous substitution rate, the E. albertii-Shigella B13 lineage is estimated to have split from an E. coli-like ancestor ∼28 million years ago and formed a distinct evolutionary branch of enteric pathogens that has radiated into groups with distinct virulence properties.
In the early 1990s, Hafnia alvei was first implicated as a causative agent of diarrhea (2). At the International Center for Diarrheal Disease Research, Dhaka, Bangladesh, clinical isolates of H. alvei were found to differ from representative H. alvei strains by phenotypic and genotypic assays, including the presence of an intimin gene (eae) homologous to the gene critical for the attaching-effacing phenotype of enteropathogenic Escherichia coli (EPEC) (3). A subsequent study identified similar H. alvei-like strains that were positive for the eae probe and, based on partial 16S rRNA sequences, were found to be more closely related to EPEC than to eae-negative H. alvei (20).
Further investigation led to the recognition of these H. alvei-like strains as a new Escherichia species, Escherichia albertii, based on the results of DNA-DNA hybridization and 16S rRNA gene sequence data (18). DNA relatedness, assessed by DNA-DNA hybridization, was highest (ranging from 54 to 64%) among E. albertii, E. coli, and Shigella flexneri, lowest (9 to 17%) between E. albertii and H. alvei, and intermediate (16 to 45%) among E. albertii and the four Escherichia species E. blattae, E. fergusonii, E. hermanii, and E. vulneris (18). Analysis of 16S rRNA gene sequences reinforced the conclusion that E. albertii does not belong to H. alvei but is most closely related to Escherichia and Shigella (18). Additionally, the structure of the O chain of the lipopolysaccharide of E. albertii has been described and does not resemble that of any known lipopolysaccharide O chain from E. coli or H. alvei; however, based on the types of sugar residues and acidity, it could fit into either group (13).
Based on genotypic analysis, another bacterium, Shigella boydii serotype 13 (Shigella B13), has also been shown to be a distant relative of E. coli representing a divergent lineage in the genus Escherichia (5, 26, 40). E. coli and Shigella have been described as one genetic species based on DNA-DNA hybridization patterns, and it has been demonstrated that although the O antigens of Shigella B13 exhibit a reciprocal cross-reaction with E. coli O28 antigens, they are genetically distinct (5). Additionally, Shigella B13 is the only member of the E. coli-Shigella group that can be reliably separated by bulk DNA-DNA hybridization techniques (5).
Nucleotide sequencing of multiple conserved genes has supported the hypothesis that E. coli and Shigella are the same genetic species and has also provided evidence that Shigella B13 belongs to a divergent branch outside the diversity of E. coli and Shigella. Furthermore, three main groups of Shigella strains are apparent, each including serotypes from the traditional Shigella species: S. boydii, S. flexneri, S. sonnei, and S. dysenteriae (26, 40). An independent multilocus sequence typing (MLST) analysis of a variety of serotypes of Shigella and enteroinvasive E. coli (EIEC) strains confirmed the presence of these three groups and supported the placement of Shigella serotypes into distinct groups within the diversity of the E. coli population; this study also placed nontypeable Shigella strains into these three groups (6).
Attachment and effacement appear to be critical components of the virulence of E. albertii (2, 3, 19). In Citrobacter rodentium and diarrheagenic E. coli, attaching-effacing lesion formation is mediated by intimin, an outer membrane protein encoded by the eae gene, and other components of the locus of enterocyte effacement pathogenicity island (34). Intimin is a highly polymorphic protein with more than 20 distinct subtypes and has been discovered in clinical isolates and animal sources (1, 25, 41, 54). The C-terminal region of the protein is the surface-exposed, immunogenic domain, which functions in binding to epithelial cells via the translocated bacterial receptor, Tir (30). In contrast, the central region is a highly conserved transmembrane domain with homology to the invasins of pathogenic Yersinia (53). Sequence comparisons have shown that intimin subtypes are encoded by distinct eae alleles with mosaic structures that presumably have arisen through lateral gene transfer and recombination (33, 48).
A second putative virulence factor discovered in E. albertii is cytolethal distending toxin (CDT) (38). In addition to strains of pathogenic E. coli and Shigella (22, 24), CDT is dispersed phylogenetically and has been found in Campylobacter spp. (23), Haemophilus ducreyi (8), Actinobacillus actinomycetemcomitans (46), and Helicobacter spp. (7, 50, 52). Cultured mammalian cell lines exposed to CDT become arrested in the G1 or G2 phase of the cell cycle, in association with cell distension and eventually death (9, 27, 28, 36). In all bacterial species in which CDT activity has been demonstrated, three closely linked genes (cdtA, cdtB, and cdtC) have been associated with cytotoxic activity (28, 36, 37, 44). Although genetic studies have indicated that all three genes are necessary to transfer full activity to a noncytotoxic E. coli strain (9, 28, 36, 37), cdtB has been implicated as encoding the enzymatically active subunit (27, 28). The CdtB subunit is homologous to a class of phosphodiesterases that includes nucleases, and it has been demonstrated that CdtB damages host cell DNA through DNase I-like activity in vitro (12, 17, 27, 32). This activity triggers the DNA damage checkpoint response (9), which results in cell cycle arrest (9, 12, 27, 28). The CdtA and CdtC subunits function together to mediate the binding of the AB2 holotoxin to eukaryotic cells and the subsequent delivery of CdtB to the cytoplasm (10, 29, 35).
The purpose of the study reported here was to elucidate the phylogenetic relationships of E. albertii and its relatives that express Shigella B13- and S. boydii serotype 7 (Shigella B7)-related antigens. In addition, we characterize the genes encoding the putative virulence factors intimin and CDT, whose role, if any, in the pathogenesis of E. albertii and relatives is not known. We propose a model, based on MLST analysis and supported by virulence gene sequences, in which the divergence of the E. albertii lineage preceded the radiation of pathogenic E. coli and Shigella. We also demonstrate that the E. albertii lineage includes other unusual strains, such as divergent Shigella B13 (5) and two nontypeable clinical isolates.
MATERIALS AND METHODS
Bacterial strains.
All strains were grown overnight in Luria-Bertani broth at 37°C. The strains examined included 5 E. albertii human clinical isolates (18, 20), 17 Shigella B13 isolates, 1 nontypeable strain, and 1 Shigella B7 isolate (Table 1). We use the nomenclature of Pupo et al. (40) in referring to the Shigella serotypes as B13 and B7.
TABLE 1.
Sources of E. albertii and Shigella strains
Strain | Species or type | Host | Locale | Sourcea |
---|---|---|---|---|
9194 | E. albertii | Human (child) | Bangladesh | J. M. Janda |
10790 | E. albertii | Human (child) | Bangladesh | J. M. Janda |
10457 | E. albertii | Human (child) | Bangladesh | J. M. Janda |
12502 | E. albertii | Human (child) | Bangladesh | J. M. Janda |
19982 | E. albertii | Human (child) | Bangladesh | J. M. Janda |
2045-54 | Shigella B13 | Human (child) | Egypt | CDC |
2046-54 | Shigella B13 | Human (child) | Egypt | CDC |
1610-55 | Shigella B13 | Monkey | United States (Fla.) | CDC |
5216-70 | Shigella B13 | Human | United States (Ohio) | CDC |
603-73 | Shigella B13 | Human | United Kingdom | CDC |
3552-77 | Shigella B13 | Human | United Kingdom | CDC |
3553-77 | Shigella B13 | Human | United Kingdom | CDC |
3554-77 | Shigella B13 | Human | United Kingdom | CDC |
3555-77 | Shigella B13 | Human | United Kingdom | CDC |
3556-77 | Shigella B13 | Human | United Kingdom | CDC |
3557-77 | Shigella B13 | Human | United Kingdom | CDC |
3052-94 | Shigella B13 | Human (infant) | New Zealand | CDC |
3053-94 | Shigella B13 | Human (19 yr) | New Zealand | CDC |
3103-99 | Shigella B13 | Human (40 yr) | United States (Ill.) | CDC |
C-425 (ATCC 12032) | Shigella B13 | Human | No data | ATCC |
616 | Shigella B13 | Human | No data | CDC |
K-694 | Shigella B13 | Human | Bangladesh | K. A. Talukder |
K-1 | Shigella B7 | Human | Bangladesh | K. A. Talukder |
3097-02 | Nontypeable | Human | United States (Wis.) | CDC |
CDC, Centers for Disease Control and Prevention; ATCC, American Type Culture Collection.
DNA isolation.
Genomic DNA was isolated from 2 ml of overnight culture by using a Puregene DNA isolation kit (Gentra Systems Inc., Minneapolis, Minn.). DNA preparations were quantified by using a NanoDrop ND-1000 UV-Vis spectrophotometer (NanoDrop Technologies, Wilmington, Del.). DNA preparations were diluted to a final concentration of 100 ng/μl and stored at 4°C.
MLST analysis.
The nucleotide sequences of internal fragments of the following genes were obtained for MLST analysis: arcA, aroE, aspC, clpX, cyaA, dnaG, fadD, grpE, icdA, lysP, mdh, mtlD, mutS, rpoS, and uidA. The analysis included 34 E. coli and Shigella strains and 2 Salmonella strains for comparison. Information on primers and protocols for MLST can be found at website http://www.shigatox.net/mlst. Sequence analysis was performed with MEGA2 software (version 2.0; Pennsylvania State University, University Park).
16S rRNA gene sequencing.
The forward primer S-D-Bact-0008-a-S-20 and the reverse primer S-*-Univ-1492-b-A-21 (45) were used to amplify bacterial 16S rRNA genes by PCR under the following conditions: 94°C for 10 min; 35 cycles of 92°C for 1 min, 58°C for 1 min, and 72°C for 1 min; and 72°C for 5 min. Additional internal sequencing primers included 16SintF1 (5′-CGG AGG GTG CAA GCG TTA AT-3′), 16SintF2 (5′-ACC CTT ATC CTT TGT TGC-3′), 16SintR1 (5′-CCA GGT AAG GTT CTT CGC GT-3′), and 16SintR2 (5′-AGT ACT TTA CAA CCC GAA GG-3′).
Diagnostic multiplex PCR.
The following primers were designed and used for diagnostic multiplex PCR: clpX_28F (5′-TGG GCT CGA GTT GGG CA-3′), clpX_411R (5′-TCC TGC TGC GGA TGT TTA CG-3′), lysP_107F (5′-GGG CGC TGC TTT CAT ATA TTC TT-3′), lysP_358R (5′-TCC AGA TCC AAC CGG GAG TAT CAG GA-3′), mdh_50F (5′-CTG GAAGGC GCA GAT GTG GTA CTG ATT-3′), and mdh_164R (5′-CTT GCT GAA CCA GAT TCT TCA CAA TAC CG-3′).
eae sequencing.
The entire eae gene, which encodes intimin, was sequenced for representative strains 19982, K-694, C-425, 3555-77, 3097-02, and K-1. PCR and sequencing primers included cesT-F9 (5′-TCA GGG AAT AAC ATT AGA AA-3′), eae-F1 (5′-ACT CCG ATT CCT CTG GTG AC-3′), eae-R3 (5′-TCT TGT GCG CTT TGG CTT-3′), and escD-R1 (5′-GTA TCA ACA TCT CCC GCC CA-3′). Internal sequencing primers included eae-F01s (5′-AAG CAA CAT GAC CGA TGA CA-3′), eae-F02s (5′-GGC GAA TAC TGG CGA GAC TA-3′), eae-F05s (5′-AGT TAA ATG CAA ATG GCG GT-3′), eae-F06s (5′-GTA ACG GAC TTT ACG GCT GAT A-3′), eae-F07s (5′-GCC TAA TAG CAT AGT GAG CGT T-3′), eae-F08s (5′-GTG ATA ATC AAA CCG CAA CT-3′), eae-F09s (5′-CGA CCT TAG GGA CGT TAA GT-3′), eae-F10s (5′-GCT TGT TAG TGC CCG AGT TC-3′), eae-R02s (5′-GGG CGC TCA TCA TAG TCT TT-3′), eae-R05s (5′-GGT AAT AAT GCC TGT ATT AG-3′), eae-R06s (5′-AGT GAG CGA GAC TGA AGT TG-3′), eae-R08s (5′-GTC GCG GTA TAA GTA AT-3′), eae-R09s (5′-TTC CTG GGA ATA ATG TTG AT-3′), eae-R10s (5′-TGG CAT GAG CTT ACA GCA TC-3′), eae-R11s (5′-CGG ATA ACG GCT TAC CAT CT-3′), and eae-R12s (5′-GCA TTA AGC GCT GAA GTC AT-3′).
cdt sequencing.
Nucleotide sequences were obtained for an internal fragment of putative virulence locus cdtB by using the primers VAT2 and WMI1 (39). Sequences for the cdtABC operon were determined for the four representative E. coli strains 19982, K-694, 3097-02, and K-1. The following additional primers were used for PCR and sequencing: cdt_5_flank_F (5′-AGG AGA TTT GCC AAT GTG AT-3′), cdt_1101_B_R (5′-GTA TCT ACA GCC GTT GAT GG-3′), cdt_1248_B_R (5′-GGC AGG CCG ATG AGG TG-3′), cdt_2057_R (5′-CGT TTG TTG AAG GTA TGA GAG-3′), and cdt_1815_F (5′-TCT ATT CAC ATT CCG CA-3′). The following primers were used for internal sequencing: cdt_584_R (5′-CCC GGG AAG CTT GTC ATA-3′) and cdt_564_F (5′-CTT TCT ACT GCA CCT TGC CA-3′). Primer randR1 (5′-TGC CGG GCA A-3′) was used for PCR.
CDT activity assays.
CDT activity assays were performed by the method of Young et al. (51, 52). Bacterial strains were grown overnight with shaking at 37°C in Luria-Bertani broth. Total bacterial proteins were solubilized with a nonionic detergent (bacterial protein extraction reagent; Pierce Chemical Co., Rockford, Ill.) according to the recommendations of the manufacturer. Bacteria were pelleted by centrifugation at 2,040 × g for 10 min, suspended in 300 μl of bacterial protein extraction reagent, and vortexed. Insoluble material was removed by centrifugation at 13,800 × g for 5 min, and soluble proteins contained in the supernatant were collected and stored at −80°C. HeLa cells were used to seed 13-mm-diameter circular glass coverslips in 24-well tissue culture plates at a density of ∼2 × 103 per well. Ten microliters of bacterial protein extract was added to each well, and the plates were incubated in 5% CO2 at 37°C. At appropriate time points, coverslips were washed with phosphate-buffered saline and then fixed and stained with a Hema 3 stain set (Fisher Scientific, Hampton, N.H.). CDT-positive E. coli 493/89 (22) and CDT-negative E. coli K-12 were used as positive and negative controls, respectively.
To confirm the CDT-positive results, CDT activity assays were also performed with Shiga toxin-insensitive CHO cells by the method of Scott and Kaper (44). CHO cells were maintained at 37°C in Ham's F-12 medium plus glutamine and supplemented with 10% fetal bovine serum, penicillin, and streptomycin. Cells were trypsinized and suspended at 2 × 104 per ml in Ham's F-12 medium with 1% fetal bovine serum, penicillin, and streptomycin. The cell suspension was added to 96-well plates at 150 μl per well. Bacterial cultures were grown with shaking overnight in Trypticase soy broth with 0.6% yeast extract. Aliquots (15 μl per well) of each test supernatant were added in triplicate to freshly plated CHO cells. Assay mixtures were incubated for 5 days at 37°C in 5% CO2 and then fixed and stained with the Hema 3 stain set.
Virulence gene profiling.
Multilocus virulence gene profiling was performed by using a Beckman (Fullerton, Calif.) CEQ8000 genetic analysis system as described previously (47) with the following modification: additional labeled primer sets were used for more extensive profiling of strains to give a total of 30 genes for fragment analysis, including an mdh control. Several primer sets were obtained from IDT (Coralville, Iowa), Proligo (Boulder, Colo.), and Research Genetics (Huntsville, Ala.). Cycling conditions were modified to include an annealing temperature of 50°C and 40 amplification cycles. Additional primer pairs can be found at website http://www.shigatox.net/mlst.
Nucleotide sequence accession numbers.
The nucleotide sequences determined in this study have been submitted to GenBank under accession numbers AY696659 to AY697031. These include accession numbers AY696752 to AY696755 for sequences for the cdtABC operon from E. coli strains 19982, K-694, 3097-02, and K-1, respectively.
RESULTS
MLST analysis.
In most cases, PCR primers used for amplifying and sequencing of E. coli and Shigella worked successfully for E. albertii, divergent Shigella B13, and related strains. The exceptions included the uidA gene, which encodes β-glucuronidase (a hallmark of typical E. coli) and was amplified in only five Shigella B13 strains: 5216-70, 3053-94, 3052-94, 3556-77, and 3557-77. In three strains, E. albertii 12502, Shigella B13 603-73, and Shigella B13 5216-70, a large (∼1.3-kb) insertion sequence was present in the region of rpoS used for MLST analysis. The insertion sequence was removed for analysis. In Shigella B13 strain 616, rpoS could not be amplified with E. coli PCR primers.
The results of PCR and sequencing of housekeeping genes allowed for a comparison of 2,484 homologous codon positions in 14 genes (uidA not included). E. albertii strains were highly divergent from E. coli strains, differing on average at ∼7.4% of the nucleotide sites from pathogenic E. coli strains (7.3% for EPEC strain E2348/69 and 7.5% for E. coli O157:H7) and 15.7% from Salmonella enterica serotype Typhimurium LT2. The E. albertii strains were most closely related to a Shigella B13 strain (ATCC 12032) (6), differing at only 0.72% of the nucleotide sites.
To assess the generality of these findings, an additional 16 Shigella B13 strains, 1 nontypeable strain, and 1 Shigella B7-related strain were examined. Five of the Shigella B13 strains (5216-70, 3053-94, 3052-94, 3556-77, and 3557-77) were phylogenetically more closely related to members of the E. coli-Shigella group than to other Shigella B13 strains (Fig. 1). These Shigella B13 strains were the same strains in which uidA could be amplified with E. coli uidA PCR primers. Strain 5216-70 (Fig. 1B) was most closely related to a group of EIEC strains (EIEC group 2) (6), whereas strains 3053-94, 3052-94, 3556-77, and 3557-77 were phylogenetically most closely related to each other and formed a distinct cluster (Fig. 1C); this cluster appears to have descended from an ancestor that also gave rise to all Shigella and EIEC groups. For clarification, these five strains are hereafter referred to as atypical Shigella B13 strains. The remaining Shigella B13 strains, the nontypeable strain, and the Shigella B7-related strain were most closely related to the E. albertii strains and are hereafter collectively referred to as the E. albertii lineage (Fig. 1A).
FIG. 1.
Phylogenetic relationships of Shigella B13 strains and the E. albertii lineage. A neighbor-joining tree (MEGA2) was constructed by using the Tamura-Nei model with gamma correction for the distribution of rates based on 14 housekeeping genes. The E. albertii lineage (A) includes E. albertii, Shigella B13, and Shigella B7. On the basis of the rate of synonymous substitutions for E. coli and S. enterica (4.7 × 10−9 per site per year), the E. albertii lineage shared a common ancestor with E. coli and Shigella pathogenic groups ∼28 million years ago (mya). Atypical S. boydii strains express the Shigella B13 antigen and do not cluster with the E. albertii lineage but are more similar in their MLST profile to E. coli and Shigella groups. Shigella B13 strain 5216-70 belongs to EIEC group 2 (B), and four atypical Shigella B13 strains belong to their own cluster within the diversity of E. coli and Shigella (C). The number of strains examined is in parentheses. NT, nontypeable; EHEC, enterohemorrhagic E. coli.
Within the E. albertii lineage, ∼1.1% (82 of 7,470) of nucleotide sites and ∼0.2% (6 of 2,490) of amino acid sites are variable. Synonymous substitution rates per 100 nucleotide sites in housekeeping genes between E. albertii and E. coli-Shigella range from a low of 10.97 for icdA to a high of 37.99 for cyaA and average 25.34, compared to an average of 5.21 ± 0.26 (mean and standard deviation) within E. coli-Shigella. Because there is substantial divergence at every locus, there is no evidence for recent recombination or gene exchange events between the E. albertii lineage and the E. coli population. Nonsynonymous substitution rates are much lower in each comparison, indicating conservative selection of housekeeping loci and allowing us to measure sequence divergence independently of adaptive evolution (Table 2). It is noteworthy that the average divergence between E. albertii and E. coli represents about 40% of the evolutionary distance from E. coli to S. enterica.
TABLE 2.
Pairwise sequence divergence among strains of the E. albertii-Shigella B13 lineage (Ea), E. coli (Ec), and S. enterica (Se)a
Locus |
dS for:
|
dN for:
|
||||
---|---|---|---|---|---|---|
Ea/Ec | Ea/Se | Ec/Se | Ea/Ec | Ea/Se | Ec/Se | |
arcA | 14.71 | 44.43 | 47.09 | 0 | 0 | 0 |
aroE | 18.94 | 112.57 | 104.86 | 1.23 | 7.98 | 7.65 |
aspC | 32.02 | 89.38 | 93.63 | 0.31 | 4.05 | 4.26 |
clpX | 12.48 | 48.27 | 44.19 | 0 | 0.77 | 0.76 |
cyaA | 37.99 | 85.85 | 53.62 | 0.01 | 0.72 | 0.73 |
dnaG | 41.17 | 78.98 | 82.81 | 0.33 | 11.83 | 11.6 |
fadD | 48.61 | 120.56 | 98.68 | 0.77 | 3.81 | 3.17 |
grpE | 12.43 | 53.97 | 46.81 | 1.02 | 5.07 | 4.71 |
icdA | 10.97 | 61.53 | 57.87 | 0 | 1.23 | 1.00 |
lysP | 31.19 | 80.85 | 73.44 | 1.84 | 3.77 | 4.09 |
mdh | 32.00 | 73.63 | 58.66 | 0.27 | 2.61 | 2.34 |
mtlD | 32.2 | 70.88 | 59.54 | 0.40 | 3.89 | 3.70 |
mutS | 19.01 | 55.09 | 62.07 | 0.57 | 1.13 | 0.85 |
rpoS | 20.84 | 28.5 | 26.44 | 0.01 | 0.01 | 0 |
Avg | 25.34 | 67.00 | 60.65 | 0.43 | 3.03 | 2.86 |
Sequence differences are expressed as the synonymous substitution rate (dS) per 100 synonymous sites and the nonsynonymous substitution rate (dN) per 100 nonsynonymous sites. Calculations were performed with MEGA2 software.
We used the combined sequences of the 14 housekeeping genes to define distinct multilocus sequence types. There were six different sequence types in the E. albertii lineage, and three different groups of sequence types can be resolved. One of the groups contains four sequence types comprised of Shigella B13 strains and nontypeable strain 3097-02. Variability within this group is low: ∼0.04% (3 of 7,470) of nucleotide sites and ∼0.08% (2 of 2,490) of amino acid sites. The remaining two sequence types each represent their own branch; the E. albertii strains all belong to one, and Shigella B7-related strain K-1 belongs to the other. In pairwise comparisons, the E. albertii group varies from the Shigella B13 group at ∼0.6% of nucleotide sites and ∼0.01% of amino acid sites and from the Shigella B7-related strain at ∼0.7% of nucleotide sites and ∼0.08% of amino acid sites. The Shigella B7-related strain differs from the Shigella B13 group by ∼0.7% of nucleotide sites and ∼0.1% of amino acid sites (Fig. 1A).
16S rRNA gene sequencing.
To assess further the genetic relatedness of the E. albertii and Shigella B13 strains, we sequenced and analyzed part of the 16S rRNA gene of all members of the E. albertii lineage and atypical Shigella B13 strains. There were 1.8% (27 of 1,464) variable sites within the lineage and five distinct sequence types divided into groups corresponding to MLST results: two groups of atypical Shigella B13 strains, one group of E. albertii strains, one group of Shigella B13 strains, and one group including the Shigella B7-related strain. In pairwise comparisons within the E. albertii lineage, the Shigella B13 and B7-related strains were the most similar (99.86%), and the Shigella B7-related and atypical Shigella B13 strains were the least similar (98.32%).
eae sequencing.
The close evolutionary relationships between E. albertii and Shigella B13 strains predicted that these bacteria should share additional chromosomal genes. We tested this prediction by attempting to detect, amplify, and sequence eae homologues in Shigella B13 and related Shigella strains of the E. albertii lineage. All strains tested were amplified, and an analysis of intimin (eae) sequences in six strains revealed three distinct eae variants, one in E. albertii strains, one in the Shigella B13 subcluster, and one in the Shigella B7-related strain. The central conserved domain of eae in six strains of the E. albertii lineage were most similar to each other, with the iota2 allele (GenBank accession number AF530553) being the most closely related E. coli allele. The C-terminal region of the intimin gene (Int280 region), in contrast to the central conserved region, which varied at 1.2% of nucleotide sites and 0.9% of amino acid sites within this lineage, differed at 37.6% of nucleotide sites and 42.3% of amino acid sites (Table 3). The Int280 region in strains of the Shigella B13 subcluster all have the same sequence, which was most similar to the iota2 allele sequence; E. albertii and Shigella B7-related strains, although possessing different alleles, are most closely related to each other, with the alpha and zeta alleles being the next most similar alleles (Fig. 2).
TABLE 3.
Sequence divergence and properties of the domain and subunits of the intimin alleles (eae) and CDT gene (cdt) of the E. albertii-Shigella B13 lineagea
Locus | No. of
|
Mean ± SD
|
dS/dN | % GC | Codon adaptation index | ||
---|---|---|---|---|---|---|---|
Alleles | Polymorphic sites | dS | dN | ||||
Entire eae | 3 | 513 | 16.06 ± 1.06 | 8.55 ± 0.63 | 1.9 | 42.0 | 0.282 |
eae 5′ region | 3 | 8 | 2.30 ± 0.79 | 0.00 ± 0.00 | 0 | 41.8 | 0.286 |
eae central region | 3 | 12 | 1.50 ± 0.51 | 0.20 ± 0.11 | 7.6 | 45.2 | 0.320 |
eae 3′ region | 3 | 493 | 41.88 ± 3.30 | 21.34 ± 1.59 | 2.0 | 39.7 | 0.253 |
cdtABC | 3 | 17 | 1.10 ± 0.36 | 0.29 ± 0.11 | 3.8 | 43.3 | 0.173 |
cdtA | 3 | 7 | 1.06 ± 0.60 | 0.46 ± 0.21 | 2.3 | 45.9 | 0.170 |
cdtB | 3 | 6 | 0.98 ± 0.54 | 0.22 ± 0.14 | 4.4 | 44.0 | 0.174 |
cdtC | 2 | 4 | 1.27 ± 0.80 | 0.08 ± 0.08 | 16.1 | 38.1 | 0.172 |
MLST genes | 6b | 82 | 1.34 ± 0.19 | 0.03 ± 0.02 | 44.1 | 52.3 | 0.448 |
See Table 2, footnote a, for definitions.
Number of distinct 14-locus sequence types.
FIG. 2.
Intimin variants of the E. albertii-Shigella B13 lineage. (A) A neighbor-joining tree (MEGA2) based on nucleotide sequences of the eae central conserved region of intimins of E. coli shows that the sequences of the intimin gene homologues of E.albertii-Shigella B13 strains are most similar to the sequence of the E. coli iota2 allele. (B) Haplotype plots of the nucleotide differences in the 3′ part of the eae gene encoding the Int280 region. The sequences of E. albertii and Shigella B7 strains are similar to the sequence of the iota2 allele of E. coli in the central conserved region but are most similar to the sequences of the alpha and zeta alleles of E. coli in the Int280 region. (C) Percent amino acid similarities among representative intimin variants. The lower triangular matrix shows pairwise similarity values for the central conserved region, and the upper triangular matrix shows values for the Int280 region. The shading highlights close similarities to the intimin domains of the E. albertii-Shigella B13 lineage (tan). C.rod, C. rodentium.
cdt sequencing and CDT expression.
Partial sequence data were determined for the cdtB subunit of members of the E. albertii lineage, and complete cdtABC sequences were obtained for representatives of the distinct subclusters of the E. albertii lineage. For atypical Shigella B13 strains and Shigella B13 strains 3553-77 and 3555-77, cdtB could not be PCR amplified. Sequence analysis of cdtABC revealed three allelic groups corresponding to the E. albertii, Shigella B13, and Shigella B7-like clusters within the lineage, consistent with evolutionary analysis of multiple housekeeping genes. The cdt sequences of the E. albertii lineage are most similar to the CDT V and CDT III variants (Fig. 3) originally found in E. coli strain 9142-88, in sorbitol-fermenting, Shiga toxin-producing E. coli O157:H− strain 493/89, and on E. coli plasmid pVIR. Although the amino acid residues in CdtB that are important for enzymatic activity have been conserved in the E. albertii lineage, all members of the Shigella B13 subcluster have a putative stop codon within the cdtB subunit (Fig. 3). Findings from subsequent experiments (see below) demonstrated that these strains do not produce stereotypical CDT activity.
FIG. 3.
Multiple sequence alignment of CdtBs from representatives of the five described E. coli alleles, CDT I (44), CDT II (37), CDT III (36), CDT IV (49), and CDT V (4, 22), and representatives of three distinct alleles of the E. albertii lineage (B13, E.alb., and B7). At amino acid position 41, shown here in a box, Shigella B13 strains are predicted to translate a stop codon rather than a tryptophan codon due to a single G-to-A transition at the second codon position. Conserved residues thought to be important for enzymatic activity (11, 35) are highlighted in gray. Arrowheads indicate residues that were mutated and shown to completely or partially abolish the cell cycle arrest activity of CDT (11, 35).
All strains were tested for the ability to produce functional CDT. HeLa cells exposed to protein extracts from whole-cell lysates of E. albertii and Shigella B7-related strains exhibited stereotypical CDT cytopathic effects, including distended cytoplasm and nuclear abnormalities. HeLa cells exposed to protein extracts from Shigella B13 strains exhibited minimal cytopathic effects (Fig. 4), consistent with the hypothesis that the stop codon in the Shigella B13 subcluster has inactivated the gene. There were no instances in which CDT activity was detected for a strain that was found to be negative for cdtB by PCR. Although none of the strains tested was found to be positive for Shiga toxin (stx) by multilocus virulence gene profiling, the CDT results were verified by the method of Scott and Kaper (44) with Shiga toxin-insensitive CHO cells (data not shown).
FIG. 4.
Cytopathic effects of bacterial cell extracts on HeLa cell monolayers. Cytoplasmic distension and nuclear abnormalities were apparent 72 h after HeLa cells were exposed to E. albertii and Shigella B7-related strains (A), whereas Shigella B13 strains did not appear to produce active toxin (B). Included for comparison are CDT-negative E. coli K-12 (C) and CDT-positive E. coli 493/89 (D). Magnification, ×40.
Virulence gene profiling.
To identify other potential virulence factors, 30 known virulence genes of E. coli and Shigella were tested for their presence in members of the E. albertii lineage (Table 4). As expected, strains of the E. albertii lineage were all positive for eae. In addition, members of the lineage were positive for at least one locus of E. coli O island 43: ureA (urease), terC (tellurite resistance), or iha (IrgA homologue adhesion). Most E. albertii strains were also positive for toxB, a toxin gene present on E. coli O157 plasmids. None of the chromosomal E. coli virulence loci examined was present in the strains examined, but pic, a secreted autotransporter toxin gene, and set1a, an enterotoxin gene present on the Shigella chromosome, were present in some strains of the E. albertii lineage. Although neither of these loci was found in atypical Shigella B13 strains, the following were present: chromosomal Shigella virulence factor gene sigA, encoding a secreted autotransporter toxin; shuA, a heme receptor gene on the outer membrane of S. dysenteriae; E. coli plasmid-carried ehx, an enterohemolysin gene; pet, an E. coli secreted autotransporter toxin gene; and astA, the EAST1 heat-stable toxin gene present in duplicate on both the chromosome and a plasmid of pathogenic E. coli. Atypical Shigella B13 strain 5216-70, which is genetically related to a group of EIEC strains, was not positive for eae.
TABLE 4.
Presence or absence of E. coli and Shigella virulence genes in the E. albertii-Shigella B13 lineage as detected by multilocus virulence gene profilinga
Strain | Lineage | Presence (+) or absence (−) of the indicated gene in:
|
|||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
E. coli
|
Shigella (chromosomal)
|
||||||||||||
O43
|
LEE (eae) | c/p (astA) | pO157 (toxB) | Plasmid
|
|||||||||
ureA | terC | iha | ehx | pet | sigA | pic | shuA | set1a | |||||
9194 | E. albertii | + | + | − | + | − | − | − | − | − | − | − | − |
10457 | E. albertii | − | − | − | + | − | + | − | − | − | − | − | − |
10790 | E. albertii | + | + | − | + | − | + | − | − | − | − | − | + |
12502 | E. albertii | − | − | − | + | − | + | − | − | − | − | − | − |
19982 | E. albertii | + | − | − | + | − | + | − | − | − | − | − | − |
2045-51 | Shigella B13 | + | + | + | + | − | − | − | − | − | − | − | − |
2046-51 | Shigella B13 | + | − | − | + | − | − | − | − | − | − | − | − |
1610-55 | Shigella B13 | + | + | + | + | − | − | − | − | − | − | − | − |
603-73 | Shigella B13 | + | − | + | + | − | − | − | − | − | − | − | − |
3552-77 | Shigella B13 | + | − | + | + | − | − | − | − | − | − | − | − |
3553-77 | Shigella B13 | + | + | + | + | − | − | − | − | − | − | − | − |
3554-77 | Shigella B13 | + | − | + | + | − | − | − | − | − | − | − | − |
3555-77 | Shigella B13 | + | + | + | + | − | − | − | − | − | − | − | − |
3103-99 | Shigella B13 | + | + | + | + | − | − | − | − | − | − | − | + |
3097-02 | Shigella B13 | + | + | + | + | − | − | − | − | − | − | − | + |
C-425 | Shigella B13 | − | − | + | + | − | − | − | − | − | − | − | + |
616 | Shigella B13 | + | + | + | + | − | − | − | − | − | − | − | − |
K-694 | Shigella B13 | − | − | + | + | − | − | − | − | − | + | − | + |
K-1 | Shigella B7 | + | − | − | + | − | − | − | − | − | − | − | − |
5216-70 | Atypical Shigella B13 | + | − | + | − | + | − | − | − | + | − | − | − |
3556-77 | Atypical Shigella B13 | − | − | − | + | + | + | − | − | − | − | + | − |
3557-77 | Atypical Shigella B13 | − | − | + | + | + | − | − | − | + | − | + | − |
3052-94 | Atypical Shigella B13 | − | − | − | + | − | − | + | + | − | − | + | − |
3053-94 | Atypical Shigella B13 | − | − | + | + | + | + | + | − | − | − | − | − |
Abbreviations: O43, O island 43 E. coli O157:H7 EDL-933; LEE, locus of enterocyte effacement; c/p, duplicate copies exist, one chromosomal and one carried on a plasmid. All strains were found to be negative by PCR for espP, espC, sepA, sat, stx1, stx2, saa, spaP, invG, shuA, cdtA, irp2, fyuA, senA, estA, bfpA, and elt.
Diagnostic multiplex PCR.
With the sequence data from the conserved housekeeping genes, we devised a multiplex PCR to detect conserved sequences that distinguish members of the E. albertii lineage from E. coli and Shigella strains. Candidate sequences with fixed differences between lineages were identified in the lysP and mdh loci. Based on nucleotide polymorphisms, primers lysP_107F and lysP_358R and primers mdh_50F and mdh_164R were designed to selectively amplify 252- and 115-bp regions, respectively, of the housekeeping genes lysP and mdh in the E. albertii lineage. As a positive control, primers clpX_28F and clpX_411R were designed to amplify a region of clpX in all E. coli and Shigella strains as well as the E. albertii lineage. A total of 134 E. coli and Shigella strains representing all major pathotypes as well as all identified members of the E. albertii lineage were analyzed by PCR (data not shown). The multiplex PCR was tested and validated with all strains of the E. albertii lineage as well as representatives of E. coli, Shigella, and Salmonella.
DISCUSSION
Following their discovery in 1991, isolates of eae-positive H. alvei were described as distinct from eae-negative H. alvei both phenotypically and genotypically (2, 3, 19-21, 43). These unusual bacteria were unlike other diarrheagenic pathogens in that they did not produce heat-labile and heat-stable enterotoxins or Shiga toxins and were not enteroinvasive. However, it was shown that they were able to cause attaching-effacing lesions accompanied by diarrhea in rabbits, as well as the typical pedestal formation and actin polymerization in vitro (2, 3, 19). Twelve years after they were first discovered, the eae-positive H. alvei isolates were elevated to a new species of pathogen within the Enterobacteriaceae (18).
It has been recognized for nearly 50 years that Shigella B13 is highly divergent from other shigellae and has been classified incorrectly (5, 14, 31, 40). For example, in a DNA relatedness study, Shigella B13 was the only known group within the E. coli-Shigella complex that could be separated with certainty (5). Later studies based on sequence analysis of multiple housekeeping genes confirmed that Shigella B13 is highly divergent from E. coli and other Shigella serotypes (40). The key characteristic of typical Shigella strains is invasiveness due to the presence of a large invasion plasmid, pINV (16). Although Shigella B13 strains were originally considered to be Shigella, there has been no evidence that they are invasive, nor do they carry the known virulence genes present on pINV. Our analyses also failed to PCR amplify pINV genes in any of the Shigella B13 strains or E. albertii strains examined by multilocus virulence gene profiling.
We conclude, based on evolutionary analyses of multiple housekeeping genes, the 16S rRNA gene, and putative virulence genes, that E. albertii and Shigella B13 strains are monophyletic and represent a distinct lineage of enteric pathogens that separated from an ancient Escherichia ancestor after E. coli and S. enterica had diverged from a common ancestor. On the basis of the rate of synonymous substitutions for E. coli and S. enterica (4.7 × 10−9 per site per year) (42), the lineage shared a common ancestor with E. coli ∼28 million years ago. The molecular evolutionary analysis supports the proposal that certain strains, such as nontypeable strain 3097-02 and Shigella B7-related strain K-1, should also be included in the new species, E. albertii.
Although most Shigella B13 strains belong to the E. albertii lineage, certain E. coli-Shigella-like strains (atypical Shigella B13 strains) also express the Shigella B13 antigen, suggesting there has been either horizontal transfer of genes responsible for this phenotype or convergence to a similar antigenic phenotype. Atypical Shigella B13 strains 3556-77 and 3557-77 were also detected as intermediate between E. coli and Shigella B13 strains by DNA relatedness, with levels similar to those found between E. coli and Shigella B13 strain but lower than those found within other Shigella B13 strains (5). The chemical and genetic organization of the O antigen of Shigella B13 was recently described; based on nucleotide sequence data, the authors concluded that the Shigella B13 rfb gene cluster was recently assembled and has also undergone recent evolutionary change (15). The inclusion of nontypeable and Shigella B7-related strains in the E. albertii lineage and the evidence for change in the genes responsible for antigenic variations suggest that the lineage may be very diverse, but that diversity has probably been seriously underestimated because of sampling bias.
To explore putative virulence factors present in the E. albertii lineage, we described two genes that E. albertii strains are known to express, the intimin (eae) (3) and CDT (cdt) (38) genes, and screened the strains for the presence of other known E. coli and Shigella virulence factors. Phylogenetic analyses of virulence genes revealed three subclusters within the E. albertii lineage, consistent with phylogenetic analyses of multiple housekeeping genes, and supported the conclusion that these strains belong to an evolutionary branch of enteric pathogens that have further diverged into three distinct groups.
The intimin gene (eae), which was found to be present in all members of the E. albertii lineage by virulence gene profiling, was sequenced in representatives of the E. albertii subclusters. Phylogenetic analyses indicated that the sequences of Shigella B13 strains, which are identical, are similar to the sequence of the iota2 allele of pathogenic E. coli. The sequences of strains 19982 (E. albertii) and K-1 (Shigella B7 related) are similar to the sequence of the iota2 allele in the central conserved region but have different alleles most similar to the alpha and zeta alleles of E. coli in the Int280 region.
CDT activity does not appear to be required for the virulence of E. albertii and its relatives. In two Shigella B13 strains (3553-77 and 3555-77), originally isolated from human patients, the cdtB gene was not amplified by PCR with degenerate primers; the remainder of the Shigella B13 strains contained a putative stop codon and lacked CDT activity. The silencing of CDT expression suggests that it does not have a required role in the virulence of these organisms. The short evolutionary distance between the active E. albertii cdt alleles and the inactive Shigella B13 cdt alleles suggests that the inactivation was a recent evolutionary event.
Both virulence genes examined have a lower GC content and a lower codon adaptation index, as measured by the rate of amelioration of GC content at the third codon positions, than do housekeeping genes (Table 3). The low codon adaptation index suggests recent acquisition of the virulence genes by lateral gene transfer. In particular, cdt sequences have a very low codon adaptation index. Levels of polymorphism within the E. albertii lineage are similar between the virulence and housekeeping genes, with the exception of the 3′ Int280 region of eae. The sequence diversity of this extracellular region in E. coli strains is thought to be under positive selection (33), and the sequence diversity in the E. albertii lineage supports the hypothesis that in the E. albertii lineage, as in E. coli, positive selection drives sequence divergence in this region.
To facilitate the economical screening of isolates, a diagnostic multiplex PCR was designed to identify bacteria of the E. albertii lineage based on sequence variations in housekeeping genes. This method of classification is independent of biochemical and antigenic phenotypes and therefore may provide a useful starting point for discovering genetic and antigenic diversity within the lineage. Infection by members of the E. albertii lineage may contribute to unexplained diarrhea, and molecular markers for the rapid detection of the new lineage will be crucial to further elucidating the role of these novel organisms in enteric disease.
Acknowledgments
We thank Lindsey Ouellette for technical assistance and Kaisar Talukder, International Center for Diarrheal Disease Research, for kindly supplying several strains used in this study.
This project was funded in part with an American Society for Microbiology undergraduate research fellowship to K.E.H. and in part with federal funds from the NIAID, NIH, and DHHS under NIH research contract N01-AI-30058.
REFERENCES
- 1.Adu-Bobie, J., G. Frankel, C. Bain, A. G. Goncalves, L. R. Trabulsi, G. Douce, S. Knutton, and G. Dougan. 1998. Detection of intimins alpha, beta, gamma, and delta, four intimin derivatives expressed by attaching and effacing microbial pathogens. J. Clin. Microbiol. 36:662-668. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Albert, M. J., K. Alam, M. Islam, J. Montanaro, A. S. Rahaman, K. Haider, M. A. Hossain, A. K. Kibriya, and S. Tzipori. 1991. Hafnia alvei, a probable cause of diarrhea in humans. Infect. Immun. 59:1507-1513. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Albert, M. J., S. M. Faruque, M. Ansaruzzaman, M. M. Islam, K. Haider, K. Alam, I. Kabir, and R. Robins-Browne. 1992. Sharing of virulence-associated properties at the phenotypic and genetic levels between enteropathogenic Escherichia coli and Hafnia alvei. J. Med. Microbiol. 37:310-314. [DOI] [PubMed] [Google Scholar]
- 4.Bielaszewska, M., M. Fell, L. Greune, R. Prager, A. Fruth, H. Tschape, M. A. Schmidt, and H. Karch. 2004. Characterization of cytolethal distending toxin genes and expression in Shiga toxin-producing Escherichia coli strains of non-O157 serogroups. Infect. Immun. 72:1812-1816. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Brenner, D. J., A. G. Steigerwalt, H. G. Wathen, R. J. Gross, and B. Rowe. 1982. Confirmation of aerogenic strains of Shigella boydii 13 and further study of Shigella serotypes by DNA relatedness. J. Clin. Microbiol. 16:432-436. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Bumbaugh, A. C., K. E. Hyma, D. W. Lacher, T. M. Large, L. M. Ouellette, C. L. Tarr, N. A. Strockbine, K. A. Talukder, D. A. Sack, and T. S. Whittam. Unpublished data.
- 7.Chien, C. C., N. S. Taylor, Z. Ge, D. B. Schauer, V. B. Young, and J. G. Fox. 2000. Identification of cdtB homologues and cytolethal distending toxin activity in enterohepatic Helicobacter spp. J. Med. Microbiol. 49:525-534. [DOI] [PubMed] [Google Scholar]
- 8.Cope, L. D., S. Lumbley, J. L. Latimer, J. Klesney-Tait, M. K. Stevens, L. S. Johnson, M. Purven, R. S. Munson, Jr., T. Lagergard, J. D. Radolf, and E. J. Hansen. 1997. A diffusible cytotoxin of Haemophilus ducreyi. Proc. Natl. Acad. Sci. USA 94:4056-4061. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Cortes-Bratti, X., T. Frisan, and M. Thelestam. 2001. The cytolethal distending toxins induce DNA damage and cell cycle arrest. Toxicon 39:1729-1736. [DOI] [PubMed] [Google Scholar]
- 10.Deng, K., and E. J. Hansen. 2003. A CdtA-CdtC complex can block killing of HeLa cells by Haemophilus ducreyi cytolethal distending toxin. Infect. Immun. 71:6633-6640. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.De Rycke, J., and E. Oswald. 2001. Cytolethal distending toxin (CDT): a bacterial weapon to control host cell proliferation? FEMS Microbiol Lett. 203:141-148. [DOI] [PubMed] [Google Scholar]
- 12.Elwell, C. A., and L. A. Dreyfus. 2000. DNase I homologous residues in CdtB are critical for cytolethal distending toxin-mediated cell cycle arrest. Mol. Microbiol. 37:952-963. [DOI] [PubMed] [Google Scholar]
- 13.Eserstam, R., T. P. Rajaguru, P. E. Jansson, A. Weintraub, and M. J. Albert. 2002. The structure of the O-chain of the lipopolysaccharide of a prototypal diarrheagenic strain of Hafnia alvei that has characteristics of a new species under the genus Escherichia. Eur. J. Biochem. 269:3289-3295. [DOI] [PubMed] [Google Scholar]
- 14.Ewing, W. H., R. W. Reavis, and B. R. Davis. 1958. Provisional Shigella serotypes. Can. J. Microbiol. 4:89-107. [DOI] [PubMed] [Google Scholar]
- 15.Feng, L., S. N. Senchenkova, J. Yang, A. S. Shashkov, J. Tao, H. Guo, G. Zhao, Y. A. Knirel, P. Reeves, and L. Wang. 2004. Structural and genetic characterization of the Shigella boydii type 13 O antigen. J. Bacteriol. 186:383-392. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Hale, T. L. 1991. Genetic basis of virulence in Shigella species. Microbiol. Rev. 55:206-224. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Hassane, D. C., R. B. Lee, and C. L. Pickett. 2003. Campylobacter jejuni cytolethal distending toxin promotes DNA repair responses in normal human cells. Infect. Immun. 71:541-545. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Huys, G., M. Cnockaert, J. M. Janda, and J. Swings. 2003. Escherichia albertii sp. nov., a diarrhoeagenic species isolated from stool specimens of Bangladeshi children. Int. J. Syst. Evol. Microbiol. 53:807-810. [DOI] [PubMed] [Google Scholar]
- 19.Ismaili, A., B. Bourke, J. C. de Azavedo, S. Ratnam, M. A. Karmali, and P. M. Sherman. 1996. Heterogeneity in phenotypic and genotypic characteristics among strains of Hafnia alvei. J. Clin. Microbiol. 34:2973-2979. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Janda, J. M., S. L. Abbott, and M. J. Albert. 1999. Prototypal diarrheagenic strains of Hafnia alvei are actually members of the genus Escherichia. J. Clin. Microbiol. 37:2399-2401. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Janda, J. M., S. L. Abbott, S. Khashe, and W. Probert. 2002. Phenotypic and genotypic properties of the genus Hafnia. J. Med. Microbiol. 51:575-580. [DOI] [PubMed] [Google Scholar]
- 22.Janka, A., M. Bielaszewska, U. Dobrindt, L. Greune, M. A. Schmidt, and H. Karch. 2003. Cytolethal distending toxin gene cluster in enterohemorrhagic Escherichia coli O157:H− and O157:H7: characterization and evolutionary considerations. Infect. Immun. 71:3634-3638. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Johnson, W. M., and H. Lior. 1988. A new heat-labile cytolethal distending toxin (CLDT) produced by Campylobacter spp. Microb. Pathog. 4:115-126. [DOI] [PubMed] [Google Scholar]
- 24.Johnson, W. M., and H. Lior. 1988. A new heat-labile cytolethal distending toxin (CLDT) produced by Escherichia coli isolates from clinical material. Microb. Pathog. 4:103-113. [DOI] [PubMed] [Google Scholar]
- 25.Jores, J., K. Zehmke, J. Eichberg, L. Rumer, and L. H. Wieler. 2003. Description of a novel intimin variant (type zeta) in the bovine O84:NM verotoxin-producing Escherichia coli strain 537/89 and the diagnostic value of intimin typing. Exp. Biol. Med. (Maywood) 228:370-376. [DOI] [PubMed] [Google Scholar]
- 26.Lan, R., and P. Reeves. 2002. Escherichia coli in disguise: molecular origins of Shigella. Microbes Infect. 4:1125. [DOI] [PubMed] [Google Scholar]
- 27.Lara-Tejero, M., and J. E. Galan. 2000. A bacterial toxin that controls cell cycle progression as a deoxyribonuclease I-like protein. Science 290:354-357. [DOI] [PubMed] [Google Scholar]
- 28.Lara-Tejero, M., and J. E. Galan. 2001. CdtA, CdtB, and CdtC form a tripartite complex that is required for cytolethal distending toxin activity. Infect. Immun. 69:4358-4365. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Lee, R. B., D. C. Hassane, D. L. Cottle, and C. L. Pickett. 2003. Interactions of Campylobacter jejuni cytolethal distending toxin subunits CdtA and CdtC with HeLa cells. Infect. Immun. 71:4883-4890. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Luo, Y., E. A. Frey, R. A. Pfuetzner, A. L. Creagh, D. G. Knoechel, C. A. Haynes, B. B. Finlay, and N. C. Strynadka. 2000. Crystal structure of enteropathogenic Escherichia coli intimin-receptor complex. Nature 405:1073-1077. [DOI] [PubMed] [Google Scholar]
- 31.Manolov, D. G. 1959. A new type of the genus Shigella—“Shigella 13.” J. Hyg. Epidemiol. Microbiol. Immunol. 3:184-190. [PubMed] [Google Scholar]
- 32.Mao, X., and J. M. DiRienzo. 2002. Functional studies of the recombinant subunits of a cytolethal distending holotoxin. Cell. Microbiol. 4:245-255. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.McGraw, E. A., J. Li, R. K. Selander, and T. S. Whittam. 1999. Molecular evolution and mosaic structure of alpha, beta, and gamma intimins of pathogenic Escherichia coli. Mol. Biol. Evol. 16:12-22. [DOI] [PubMed] [Google Scholar]
- 34.Nataro, J. P., and J. B. Kaper. 1998. Diarrheagenic Escherichia coli. Clin. Microbiol. Rev. 11:142-201. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Nesic, D., Y. Hsu, and C. E. Stebbins. 2004. Assembly and function of a bacterial genotoxin. Nature 429:429-433. [DOI] [PubMed] [Google Scholar]
- 36.Peres, S. Y., O. Marches, F. Daigle, J. P. Nougayrede, F. Herault, C. Tasca, J. De Rycke, and E. Oswald. 1997. A new cytolethal distending toxin (CDT) from Escherichia coli producing CNF2 blocks HeLa cell division in G2/M phase. Mol. Microbiol. 24:1095-1107. [DOI] [PubMed] [Google Scholar]
- 37.Pickett, C. L., D. L. Cottle, E. C. Pesci, and G. Bikah. 1994. Cloning, sequencing, and expression of the Escherichia coli cytolethal distending toxin genes. Infect. Immun. 62:1046-1051. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Pickett, C. L., R. B. Lee, A. Eyigor, B. Elitzur, E. M. Fox, and N. A. Strockbine. 2004. Patterns of variations in Escherichia coli strains that produce cytolethal distending toxin. Infect. Immun. 72:684-690. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Pickett, C. L., E. C. Pesci, D. L. Cottle, G. Russell, A. N. Erdem, and H. Zeytin. 1996. Prevalence of cytolethal distending toxin production in Campylobacter jejuni and relatedness of Campylobacter sp. cdtB gene. Infect. Immun. 64:2070-2078. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Pupo, G. M., R. Lan, and P. R. Reeves. 2000. Multiple independent origins of Shigella clones of Escherichia coli and convergent evolution of many of their characteristics. Proc. Natl. Acad. Sci. USA 97:10567-10572. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Ramachandran, V., K. Brett, M. A. Hornitzky, M. Dowton, K. A. Bettelheim, M. J. Walker, and S. P. Djordjevic. 2003. Distribution of intimin subtypes among Escherichia coli isolates from ruminant and human sources. J. Clin. Microbiol. 41:5022-5032. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Reid, S. D., C. J. Herbelin, A. C. Bumbaugh, R. K. Selander, and T. S. Whittam. 2000. Parallel evolution of virulence in pathogenic Escherichia coli. Nature 406:64-67. [DOI] [PubMed] [Google Scholar]
- 43.Ridell, J., A. Siitonen, L. Paulin, O. Lindroos, H. Korkeala, and M. J. Albert. 1995. Characterization of Hafnia alvei by biochemical tests, random amplified polymorphic DNA PCR, and partial sequencing of 16S rRNA gene. J. Clin. Microbiol. 33:2372-2376. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Scott, D. A., and J. B. Kaper. 1994. Cloning and sequencing of the genes encoding Escherichia coli cytolethal distending toxin. Infect. Immun. 62:244-251. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Suau, A., R. Bonnet, M. Sutren, J. J. Godon, G. R. Gibson, M. D. Collins, and J. Dore. 1999. Direct analysis of genes encoding 16S rRNA from complex communities reveals many novel molecular species within the human gut. Appl. Environ. Microbiol. 65:4799-4807. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Sugai, M., T. Kawamoto, S. Y. Peres, Y. Ueno, H. Komatsuzawa, T. Fujiwara, H. Kurihara, H. Suginaka, and E. Oswald. 1998. The cell cycle-specific growth-inhibitory factor produced by Actinobacillus actinomycetemcomitans is a cytolethal distending toxin. Infect. Immun. 66:5008-5019. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Tarr, C. L., T. M. Large, C. L. Moeller, D. W. Lacher, P. I. Tarr, D. W. Acheson, and T. S. Whittam. 2002. Molecular characterization of a serotype O121:H19 clone, a distinct Shiga toxin-producing clone of pathogenic Escherichia coli. Infect. Immun. 70:6853-6859. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Tarr, C. L., and T. S. Whittam. 2002. Molecular evolution of the intimin gene in O111 clones of pathogenic Escherichia coli. J. Bacteriol. 184:479-487. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Toth, I., F. Herault, L. Beutin, and E. Oswald. 2003. Production of cytolethal distending toxins by pathogenic Escherichia coli strains isolated from human and animal sources: establishment of the existence of a new cdt variant (type IV). J. Clin. Microbiol. 41:4285-4291. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Young, V. B., C. C. Chien, K. A. Knox, N. S. Taylor, D. B. Schauer, and J. G. Fox. 2000. Cytolethal distending toxin in avian and human isolates of Helicobacter pullorum. J. Infect. Dis. 182:620-623. [DOI] [PubMed] [Google Scholar]
- 51.Young, V. B., K. A. Knox, J. S. Pratt, J. S. Cortez, L. S. Mansfield, A. B. Rogers, J. G. Fox, and D. B. Schauer. 2004. In vitro and in vivo characterization of Helicobacter hepaticus cytolethal distending toxin mutants. Infect. Immun. 72:2521-2527. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Young, V. B., K. A. Knox, and D. B. Schauer. 2000. Cytolethal distending toxin sequence and activity in the enterohepatic pathogen Helicobacter hepaticus. Infect. Immun. 68:184-191. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Yu, J., and J. B. Kaper. 1992. Cloning and characterization of the eae gene of enterohaemorrhagic Escherichia coli O157:H7. Mol. Microbiol. 6:411-417. [DOI] [PubMed] [Google Scholar]
- 54.Zhang, W. L., B. Kohler, E. Oswald, L. Beutin, H. Karch, S. Morabito, A. Caprioli, S. Suerbaum, and H. Schmidt. 2002. Genetic diversity of intimin genes of attaching and effacing Escherichia coli strains. J. Clin. Microbiol. 40:4486-4492. [DOI] [PMC free article] [PubMed] [Google Scholar]